Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia

IntroductionThe mechanistic/mammalian target of rapamycin (mTOR) is a serine/threonine kinase, which is downregulated or upregulated and is implicated in different types of cancer including hematologic neoplasms, skin prostate, and head and neck cancer.AimThe aim of this study was to explore the cur...

Full description

Bibliographic Details
Main Authors: Miguel Enrique Cuéllar Mendoza, Francisco Raúl Chávez Sánchez, Elisa María Dorantes Acosta, Ana María Niembro Zúñiga, Rosana Pelayo, Marta Zapata Tarrés
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
mTOR
acute lymphoblastic leukemia
Hodgkin lymphoma
mTORC1
mTORC2
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1304605/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1304605/full

Similar Items